4 - AlTi Global, Inc. (0001838615) (Issuer)

4 - AlTi Global, Inc. (0001838615) (Issuer)

4 - AlTi Global, Inc. (0001838615) (Issuer)

4 - AlTi Global, Inc. (0001838615) (Issuer)

4 - AlTi Global, Inc. (0001838615) (Issuer)

4/A - AlTi Global, Inc. (0001838615) (Issuer)

4 - AlTi Global, Inc. (0001838615) (Issuer)

4 - AlTi Global, Inc. (0001838615) (Issuer)

4 - AlTi Global, Inc. (0001838615) (Issuer)

4 - AlTi Global, Inc. (0001838615) (Issuer)

13F-HR - AlTi Global, Inc. (0001838615) (Filer)

10-Q - AlTi Global, Inc. (0001838615) (Filer)

424B3 - AlTi Global, Inc. (0001838615) (Filer)

8-K - AlTi Global, Inc. (0001838615) (Filer)

424B3 - AlTi Global, Inc. (0001838615) (Filer)

8-K - AlTi Global, Inc. (0001838615) (Filer)

8-K - AlTi Global, Inc. (0001838615) (Filer)

424B3 - AlTi Global, Inc. (0001838615) (Filer)

10-Q - AlTi Global, Inc. (0001838615) (Filer)

424B3 - AlTi Global, Inc. (0001838615) (Filer)

SC 13G/A - AlTi Global, Inc. (0001838615) (Subject)

SC 13D/A - AlTi Global, Inc. (0001838615) (Subject)

SC 13D/A - AlTi Global, Inc. (0001838615) (Subject)

SC 13G/A - Alvarium Tiedemann Holdings, Inc. (0001838615) (Subject)

SC 13G - Alvarium Tiedemann Holdings, Inc. (0001838615) (Subject)

SC 13D - Alvarium Tiedemann Holdings, Inc. (0001838615) (Subject)

SC 13D - Alvarium Tiedemann Holdings, Inc. (0001838615) (Subject)

SC 13D - Alvarium Tiedemann Holdings, Inc. (0001838615) (Subject)

SC 13D - Alvarium Tiedemann Holdings, Inc. (0001838615) (Subject)

SC 13G - Alvarium Tiedemann Holdings, Inc. (0001838615) (Subject)

– Provides financial flexibility to execute growth initiatives and serve its global clients more efficiently – Alvarium Tiedemann Holdings, Inc. (NASDAQ:ALTI) ("Alvarium Tiedemann" or "AlTi" or the "Company") announced today that it has entered into a $250 million credit facility with a syndicate led by BMO Capital Markets Corp. ("BMO"). The facility, which is comprised of a $150 million revolving credit facility and a $100 million term loan facility, will be used to pay down subsidiary debt and fund growth initiatives. The new credit facility, which has a term of five years, will allow Alvarium Tiedemann to strategically expand its global footprint, platform and opportunity set across bu

– Alvarium Tiedemann Holdings to Commence Trading on NASDAQ Under Ticker "ALTI" on January 4, 2023 – Tiedemann Group ("Tiedemann"), Alvarium Investments Limited ("Alvarium") and Cartesian Growth Corporation ("Cartesian") (NASDAQ:GLBL) announced today that they have completed their previously announced business combination (the "Business Combination"). The Business Combination was approved at an extraordinary general meeting of stockholders of Cartesian on November 17, 2022, and closed today, January 3, 2023. The combined company now operates as Alvarium Tiedemann Holdings, Inc. ("Alvarium Tiedemann" or "AlTi") and its Class A common shares and warrants will begin trading on NASDAQ under th

– Combined company will operate as Alvarium Tiedemann Holdings, Inc. and will be listed on NASDAQ under the ticker symbol "ALTI" on January 4, 2023 – Tiedemann Group ("Tiedemann"), Alvarium Investments Limited ("Alvarium") and Cartesian Growth Corporation ("Cartesian") (NASDAQ:GLBL), announced today that upon closing, the combined company Alvarium Tiedemann Holdings, Inc. ("Alvarium Tiedemann" or "AlTi" or the "Company") and its common stock and warrants will be listed on NASDAQ under the updated ticker symbols "ALTI" and "ALTIW," respectively. No action by the Company's shareholders is required with respect to the ticker symbol change and the change, once effected, will not affect the ex

– Expected closing date on or about January 3, 2023 – – Combined company to operate as Alvarium Tiedemann Holdings ("AlTi") and expected to begin trading on NASDAQ under ticker "GLBL" on or about January 4, 2023 – Cartesian Growth Corporation ("Cartesian") (NASDAQ:GLBL), a publicly traded special purpose acquisition company, announced today that in an extraordinary general meeting on November 17, 2022, its shareholders voted to approve its proposed business combination (the "Business Combination") with Tiedemann Group ("Tiedemann") and Alvarium Investments Limited ("Alvarium"). Closing-related processes are underway; in the interest of merger-accounting simplicity, the closing will be he

– Extraordinary general meeting of shareholders to approve proposed business combination to be held November 17, 2022 – – Upon closing, the combined company will operate as Alvarium Tiedemann Holdings ("Alvarium Tiedemann" or "AlTi") and will be listed on NASDAQ under the ticker symbol "GLBL" – Cartesian Growth Corporation ("Cartesian") (NASDAQ:GLBL), a publicly traded special purpose acquisition company, today announced that the U.S. Securities and Exchange Commission ("SEC") has declared effective its registration statement on Form S-4 (File No. 333-262644) (the "Registration Statement"), which includes a definitive proxy statement in connection with Cartesian's extraordinary general me

– Expected to Close in the Second Half of 2022, Subject to SEC Process and Shareholder Approval – Cartesian Growth Corporation ("Cartesian") (NASDAQ:GLBL), a publicly traded special purpose acquisition company, today announced that it has received the required pre-closing approvals from the applicable regulatory and governmental authorities in certain jurisdictions where Tiedemann Group ("Tiedemann") and Alvarium Investments Limited ("Alvarium") operate with respect to the previously announced business combination among Cartesian, Tiedemann and Alvarium. Upon closing of the transaction, the combined company will operate as Alvarium Tiedemann Holdings ("Alvarium Tiedemann - AlTi") and will

– Board of Director Appointments Bring Deep Domain Expertise and Experience in Scaling Wealth and Asset Management Platforms – – 2021 Financial Performance for the Constituent Firms was Robust and in Line with Previously Disclosed Estimates – – Business Combination with Cartesian Growth Corporation is Progressing and with Executed Extension Expected to Close in Summer of 2022 – Tiedemann Group1 ("Tiedemann"), Alvarium Investments Limited2 ("Alvarium"), and Cartesian Growth Corporation3 ("Cartesian") (NASDAQ:GLBL), today announced the selection of director nominees to serve on the future board of the combined company Alvarium Tiedemann Holdings ("Alvarium Tiedemann"). The Alvarium Tiedema

Cartesian Growth Corporation ("Cartesian") (NASDAQ:GLBL), a publicly traded special purpose acquisition company, today announced the filing with the U.S. Securities and Exchange Commission (the "SEC") of a registration statement on Form S-4 (the "Registration Statement") in connection with the previously announced proposed business combination among Cartesian, Tiedemann Group1 ("Tiedemann") and Alvarium Investments Limited2 ("Alvarium"). The proposed business combination will form Alvarium Tiedemann Holdings ("Alvarium Tiedemann"). The Registration Statement contains a preliminary proxy statement and prospectus in connection with the proposed business combination. While the Registration St

The Tiedemann and Alvarium groups intend to combine with Cartesian Growth Corporation (NASDAQ:GLBL), a special purpose acquisition company, to form Alvarium Tiedemann Holdings ("Alvarium Tiedemann" or "AlTi"), creating a leading independent, global wealth and asset manager providing entrepreneurs, multi-generational families, institutions and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and strategic advisory services. The combined company is expected to oversee $54 billion in assets under management (AUM) and assets under advisement (AUA) on behalf of families and institutions around the world. The combined company is expect

Alvarium Tiedemann Holdings, Inc. (NASDAQ:ALTI) ("Alvarium Tiedemann" or "AlTi" or the "Company") announced that in accordance with the Sponsor Support Agreement, dated as of September 19, 2021 (as amended, the "Sponsor Support Agreement"), at the closing of the Business Combination, Cartesian's sponsor, CGC Sponsor LLC, forfeited a total of 2,118,569 shares of Class A common stock, which shares were issued to public shareholders of Cartesian who did not elect to redeem their shares and investors in the private placement consummated concurrently with the closing of the Business Combination (collectively, the "Bonus Shares"). The Bonus Shares were issued pro rata based on the number of share

– Combined company will operate as Alvarium Tiedemann Holdings, Inc. and will be listed on NASDAQ under the ticker symbol "ALTI" on January 4, 2023 – Tiedemann Group ("Tiedemann"), Alvarium Investments Limited ("Alvarium") and Cartesian Growth Corporation ("Cartesian") (NASDAQ:GLBL), announced today that upon closing, the combined company Alvarium Tiedemann Holdings, Inc. ("Alvarium Tiedemann" or "AlTi" or the "Company") and its common stock and warrants will be listed on NASDAQ under the updated ticker symbols "ALTI" and "ALTIW," respectively. No action by the Company's shareholders is required with respect to the ticker symbol change and the change, once effected, will not affect the exi

Gainers Satixfy Communications Ltd. (NYSE:SATX) jumped 96.4% to settle at $51.70 on Thursday. Elevate Credit, Inc. (NYSE:ELVT) shares jumped 68.9% to close at $1.79 on Thursday after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million. Ardelyx Inc (NASDAQ:ARDX) shares climbed 41% to close at $1.72 as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. CytomX Therapeutics, Inc. (NASDAQ:CTMX) gained 32.2% to close at $1.60 after the company and Regeneron announced a s

U.S. stocks closed slightly lower on Thursday, with the S&P 500 dropping around 0.3%. Here is the list of some big stocks recording gains in the previous session. Satixfy Communications Ltd. (NYSE:SATX) jumped 96.4% to settle at $51.70 on Thursday. Ardelyx Inc (NASDAQ:ARDX) shares climbed 41% to close at $1.72 as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. Atour Lifestyle Holdings Limited (NASDAQ:ATAT) climbed 31% to close at $14.92. NWTN Inc. (NASDAQ:NWTN) gained 29.8% to settle at $4.10. Bath & Body Works, Inc. (NYSE:BBWI) jumped

Gainers Elevate Credit, Inc. (NYSE:ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million. Ardelyx Inc (NASDAQ:ARDX) shares jumped 45.1% to $1.7699 as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. Satixfy Communications Ltd. (NYSE:SATX) gained 37.3% to $36.14. Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) surged 37.2% to $3.57. CytomX Therapeutics, Inc. (NASDAQ:CTMX) jumped 24.8% to $1.5110 after the company and Reg

U.S. stocks traded lower this morning, with the Dow Jones dropping over 200 points on Thursday. Following the market opening Thursday, the Dow traded down 0.70% to 33,318.50 while the NASDAQ fell 1.25% to 11,044.04. The S&P 500 also fell, dropping, 1.08% to 3,915.88. Also check this: Nasdaq Drops Sharply, But Market Volatility Decreases Leading and Lagging Sectors Consumer staples shares fell by just 0.4% on Thursday. Leading the sector was strength from RLX Technology Inc. (NYSE:RLX) and Dole plc (NYSE:DOLE). In trading on Thursday, communication services dipped by 1.9%. Top Headline   US jobless claims dropped by 4,000 to 222,000 on the week ending November 12th, compared to

Gainers Ardelyx Inc (NASDAQ:ARDX) shares rose 81.2% to $2.21 in pre-market trading as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. Elevate Credit, Inc. (NYSE:ELVT) shares rose 65.1% to $1.75 in pre-market trading after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million. Cuentas Inc. (NASDAQ:CUEN) rose 29.6% to $0.3239 in pre-market trading after dropping 28% on Wednesday. Cuentas authorized a share repurchase program. Bath & Body Works, Inc. (NYSE:BBWI) rose

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. Ardelyx Inc (NASDAQ:ARDX) shares jumped 81.2% to $2.21 in pre-market trading as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. Bath & Body Works, Inc. (NYSE:BBWI) climbed 22.3% to $38.09 in pre-market trading after the company reported better-than-expected Q3 results and raised FY22 earnings forecast. SomaLogic, Inc. (NASDAQ:SLGC) surged 14.5% to $3.08 in pre-market trading. The company recently posted upbeat Q3